Physician profile
James A Carr
NPI 1336225390
$506.98
in general payments reported to CMS, 2019-2025
12 companies · $19.65 in 2025
The $19.65 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.59 · 2020: $53.98 · 2021: $70.37 · 2022: $14.65 · 2023: $214 · 2024: $112 · 2025: $19.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $127.75 | 2023-2024 | Myfembree |
| Abbvie INC. | $124.35 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.94 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $34.92 | 2024 | |
| Organon LLC | $28.75 | 2023 | Nexplanon |
| Lsi Solutions INC | $25.67 | 2024 | Fornisee |
| Hologic Sales and Service, LLC | $23.83 | 2023 | Acessa Provu System |
| Allergan, INC. | $22.59 | 2019 | |
| Astellas Pharma US INC | $20.17 | 2024 | Veozah |
| Convatec INC. | $19.67 | 2023 | |
| Horizon Therapeutics Plc | $18.69 | 2023 | Krystexxa |
| Scynexis, INC. | $14.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.